Mitchell Levinson compensation by year
PULSE BIOSCIENCES Summary Compensation Table · all 3 fiscal years held| Component | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Salary | $131,250 | $360,000 | $369,563 |
| Bonus | $0 | $0 | $213,582 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $930,748 | $0 | $1,109,997 |
| Non-equity incentive | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $418 | $1,338 | $1,420 |
| Total | $1,062,416 | $361,338 | $1,694,562 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PULSE BIOSCIENCES, INC. DEF 14A filed April 23, 2024, accession 0001437749-24-012863, and prior-year filings. Open the filing on EDGAR.
How this page was built: the PULSE BIOSCIENCES, INC. filed document, accession 0001437749-24-012863. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2024.
Equity holdings
unvested awards at FY2021 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 32,755 | — | $21.12 |
| Option | 32,755 | — | $21.12 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PULSE BIOSCIENCES, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
30 Form 4 lines since the FY2023 proxy (filed April 23, 2024)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2024-09-24 | Exercise | — | 1,240 | $11.00 | 21,240 |
| 2024-09-24 | Exercise | — | 322 | $11.00 | 8,321 |
| 2024-09-24 | Exercise | — | 322 | $11.00 | 8,421 |
| 2024-09-24 | Exercise | — | 322 | $11.00 | 8,521 |
| 2024-09-24 | Exercise derivative | — | 1,500 | — | 0 |
| 2024-09-24 | Exercise derivative | — | 1,500 | — | 0 |
| 2024-09-24 | Exercise derivative | — | 620 | — | 1 |
| 2024-09-24 | Exercise | — | 3,000 | $11.00 | 93,880 |
The 8 most recent of 30 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
PULSE BIOSCIENCES’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Kevin Danahy | Chief Executive Officer | $5,864,450 |
| Darrin Uecker | Chief Technology Officer and Director | $5,390,028 |
| Mitchell Levinson · this page | Chief Strategy Officer | $1,694,562 |
Board service
PULSE BIOSCIENCES board · FY2021| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2021 | $92,258 | — | $785,502 | — | $877,760 |
Each year as the company reported it in PULSE BIOSCIENCES's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: PULSE BIOSCIENCES pays directors a $40,000 cash retainer. As stated in PULSE BIOSCIENCES's FY2021 proxy.
The full PULSE BIOSCIENCES compensation record
free company briefThis page is one person within PULSE BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PULSE BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.